BHCM
EDIT icon

Brevan Howard Capital Management’s Editas Medicine EDIT Stock Holding History

Brevan Howard Capital Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-30,116
Closed -$103K – 1140
2024
Q3 		$103K Sell
30,116
-48,952
-62% -$213K ﹤0.01% 1074
2024
Q2 		$369K Buy
+79,068
New +$446K ﹤0.01% 710
2021
Q3 		– Sell
-47,176
Closed -$2.67M – 41
2021
Q2 		$2.67M Hold
47,176
– – 0.73% 25
2021
Q1 		$1.98M Sell
47,176
-29,244
-38% -$1.67M 0.29% 41
2020
Q4 		$5.36M Buy
+76,420
New +$3.14M 1.07% 18

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brevan Howard Capital Management's EDIT Position: Q4 2024 in Review

Brevan Howard Capital Management sold out of Editas Medicine (EDIT) in Q4 2024, closing a stake of 30,116 shares — an estimated $103K sold.

Brevan Howard Capital Management first reported a position in EDIT in Q4 2020 and held it in 5 quarters. The position peaked at $5.36M in Q4 2020. 206 funds tracked by Wall St. Rank hold EDIT as of Q4 2024.

  • Brevan Howard Capital Management reported no remaining Editas Medicine position as of Q4 2024 after selling out during the quarter.
  • Brevan Howard Capital Management sold 30,116 Editas Medicine shares in Q4 2024, an estimated $103K.
  • Brevan Howard Capital Management first reported a position in Editas Medicine in Q4 2020 and held it in 5 quarters.
  • Brevan Howard Capital Management's Editas Medicine position peaked at $5.36M in Q4 2020.
  • 206 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2024.

Based on Brevan Howard Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.